Eton Pharmaceutcials
ETON
37 hedge funds and large institutions have $29.5M invested in Eton Pharmaceutcials in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 17 closing their positions.
92% more call options, than puts
Call options by funds: $637K | Put options by funds: $331K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
3.67% less ownership
Funds ownership: 27.91% → 24.24% (-3.7%)
20% less funds holding
Funds holding: 46 → 37 (-9)
38% less capital invested
Capital invested by funds: $48M → $29.5M (-$18.4M)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$611K |
| 2 |
Bank of New York Mellon
New York
|
+$346K |
| 3 |
Morgan Stanley
New York
|
+$172K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$160K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$133K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.14M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.01M |
| 3 |
Millennium Management
New York
|
-$592K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$523K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$484K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCA
51
Berman Capital Advisors
Atlanta,
Georgia
| – | -$1K | -229 | Closed |
|
52
JP Morgan Chase
New York
| – | -$1K | -153 | Closed |
|
53
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -135 | Closed |
|
ETON Hedge Fund Activity: Q3 2021 in Review
37 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2021, worth a combined $29.5M — down 38% from $48M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ETON and 8 opened new positions — a net loss of 9 holders — while 10 trimmed existing stakes and 10 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $611K. The largest seller was Opaleye Management, cutting an estimated $3.14M.
- 37 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2021, down from 46 in Q2 2021.
- Funds reported $29.5M of Eton Pharmaceutcials stock for Q3 2021, down 38% quarter-over-quarter.
- 8 funds opened new Eton Pharmaceutcials positions in Q3 2021 and 17 closed out, a net change of -9 holders.
- The largest Eton Pharmaceutcials buyer in Q3 2021 was Susquehanna International Group, an estimated $611K added.
- The largest Eton Pharmaceutcials seller in Q3 2021 was Opaleye Management, an estimated $3.14M sold.
Based on aggregated 13F filings for Q3 2021.